C82.56 Diffuse follicle center lymphoma, intrapelvic lymph nodes

Name of the Condition

• Diffuse Follicle Center Lymphoma, Intrapelvic Lymph Nodes

Summary

Diffuse follicle center lymphoma is a type of non-Hodgkin lymphoma that originates in the lymphatic system, specifically affecting B-cells. It is characterized by the proliferation of cancerous lymphocytes, which can accumulate in lymph nodes and other tissues. When localized to intrapelvic lymph nodes, it involves the lymph nodes within the pelvic region, such as those near the bladder, rectum, or reproductive organs. This condition may present with varying clinical behavior, ranging from indolent to more aggressive forms.

Causes

The exact cause of diffuse follicle center lymphoma is not fully understood, but it is associated with genetic mutations in B-cells. Environmental factors and immune system dysfunction may contribute to its development.

Risk Factors

• Age: More common in individuals over 60.
• Family history: A history of lymphoma can increase risk.
• Immune system deficiencies.
• Certain infections, such as hepatitis C.

Symptoms

• Painless swelling of lymph nodes in the pelvic area.
• Fatigue.
• Night sweats.
• Unexplained weight loss.
• Fever.
• Abdominal or pelvic discomfort.

Diagnosis

Diagnosis involves a physical examination, medical history review, blood tests, imaging studies (e.g., CT or PET scans), and a biopsy of affected lymph nodes to confirm the presence and subtype of lymphoma. Imaging may focus on the pelvic region to assess lymph node involvement.

Treatment Options

• Watchful waiting: Monitoring the condition without immediate treatment if symptoms are mild.
• Radiation therapy: Targeted treatment for localized disease in the pelvic region.
• Chemotherapy: Systemic treatment to address widespread or aggressive disease.
• Immunotherapy: Therapies that enhance the immune system's ability to target cancer cells.
• Stem cell transplant: Considered for relapsed or refractory cases.

Prognosis and Follow-Up

Prognosis depends on factors such as the stage of the disease, overall health, and response to treatment. Regular follow-up with imaging and clinical assessments is essential to monitor for recurrence or progression. Long-term surveillance may be required, especially if the disease is aggressive.

Complications

• Spread of lymphoma to other organs or lymph node regions.
• Treatment-related side effects, such as infection risk from chemotherapy.
• Organ dysfunction if lymph nodes compress nearby structures (e.g., bladder or bowel).

Lifestyle & Prevention

• Maintain a healthy immune system through balanced nutrition and regular exercise.
• Avoid known risk factors, such as smoking or excessive alcohol consumption.
• Stay up-to-date with vaccinations to reduce infection risk, especially during treatment.

When to Seek Professional Help

Seek medical attention if you experience persistent pelvic swelling, unexplained weight loss, night sweats, or fatigue. Prompt evaluation is important for early diagnosis and management.

Tips for Medical Coders

When coding for diffuse follicle center lymphoma involving intrapelvic lymph nodes, ensure the documentation specifies the anatomical location (intrapelvic) to support the use of code C82.56. Verify that the diagnosis aligns with the clinical findings and that any relevant staging or treatment details are documented to support accurate coding.